NFKB2 Antibody - N-terminal region

Artikelnummer: ASB-ARP32718_P050
Artikelname: NFKB2 Antibody - N-terminal region
Artikelnummer: ASB-ARP32718_P050
Hersteller Artikelnummer: ARP32718_P050
Alternativnummer: ASB-ARP32718_P050-25UL,ASB-ARP32718_P050-100UL
Hersteller: Aviva
Wirt: Rabbit
Kategorie: Proteine/Peptide
Applikation: IHC, WB
Spezies Reaktivität: Bovine, Canine, Equine, Guinea pig, Human, Mouse, Rabbit, Rat
Immunogen: The immunogen is a synthetic peptide directed towards the N terminal region of human NFKB2
Alternative Synonym: p52, p100, H2TF1, LYT10, CVID10, LYT-10, NF-kB2, p49/p100
NFKB has been detected in numerous cell types that express cytokines, chemokines, growth factors, cell adhesion molecules, and some acute phase proteins in health and in various disease states. NFKB is activated by a wide variety of stimuli such as cytokines, oxidant-free radicals, inhaled particles, ultraviolet irradiation, and bacterial or viral products. Inappropriate activation of NF-kappa-B has been linked to inflammatory events associated with autoimmune arthritis, asthma, septic shock, lung fibrosis, glomerulonephritis, atherosclerosis, and AIDS. In contrast, complete and persistent inhibition of NF-kappa-B has been linked directly to apoptosis, inappropriate immune cell development, and delayed cell growth.
Klonalität: Polyclonal
Konzentration: 0.5 mg/ml
Molekulargewicht: 101kDa
NCBI: 4791
UniProt: Q00653
Formulierung: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Human Lung
WB Suggested Anti-NFKB2 Antibody Titration: 0.2-1 ug/ml
Positive Control: Raji cell lysateNFKB2 is strongly supported by BioGPS gene expression data to be expressed in Human Raji cells
NFKB2 antibody - N-terminal region (ARP32718_P050) in Human Raji using Western Blot